USV Limited manufactures Oligopeptide for Preventing Platelet-Associated Ischemic Disorders. USV Limited also offers various types of Generics, Active Pharmaceutical Ingredients and Biotherapeutics. The Oligopeptide for Preventing Platelet-Associated Ischemic Disorders is used as an anti-coagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty. The Oligopeptide for Preventing Platelet-Associated Ischemic Disorders is produced using a method based on solid-phase peptide synthesis Technology. The Oligopeptide for Preventing Platelet-Associated Ischemic Disorders is marketed under the brand name `Gioloc`.
